Short-term effect of zidovudine on plasma and genital human immunodeficiency virus type 1 and viral turnover in these compartments

Journal of Virology

Volumn 77, Issue 13, 2003, Pages 7702-7705

  Mbori Ngacha, Dorothy ^a   Richardson, Barbra A ^b,c   Overbaugh, Julie ^c   DeVange Panteleeff, Dana ^c   Nduati, Ruth ^a   Steele, Matt ^b   John Stewart, Grace ^a,b,d  

^a UNIVERSITY OF NAIROBI   (Kenya)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d IARTP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG ACTIVITY; FEMALE; HALF LIFE TIME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; TISSUE LEVEL; UTERINE CERVIX; VAGINA;

CERVIX UTERI; FEMALE; HALF-LIFE; HIV INFECTIONS; HIV-1; HUMANS; REVERSE TRANSCRIPTASE INHIBITORS; RNA, VIRAL; VAGINA; VIRUS REPLICATION; ZIDOVUDINE;

EID: 0038128513     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.13.7702-7705.2003     Document Type: Article

References (22)

1. Blankson, J. N., D. Persaud, and R. Siciliano. 2002. The challenge of viral reservoirs in HIV-1 infection. Annu. Rev. Med. 53:557-593.
2. Cavert, W., D. W. Notermans, K. Staskus, S. W. Wietgrefe, M. Zupancic, K. Gebhard, K. Henry, Z. Q. Zhang, R. Mills, H. McDade, C. M. Schuwirth, J. Goudsmit, S. A. Danner, and A. T. Haase. 1997. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science 276:960-964.
3. Chuachoowong, R., N. Shaffer, W. Siriwasin, P. Chaisilwattana, N. L. Young, P. A. Mock, S. Chearskul, N. Waranawat, T. Chaowanachan, J. Karon, R. J. Simonds, T. D. Mastro, et al. 2000. Short-course antenatal zidovudine reduces both cervicovaginal human immunodeficiency virus type 1 RNA levels and risk of perinatal transmission. J. Infect. Dis. 181:99-106.
4. Connor, E. M., R. S. Sperling, R. Gelber, P. Kiselev, G. Scott, M. J. O'Sullivan, R. VanDyke, M. Bey, W. Shearer, R. L. Jacobson, et al. 1994. Reduction of maternal-infant transmission of human immunodeficiency virus type-1 with zidovudine treatment. N. Engl. J. Med. 331:1173-1180.
5. Ekpini, R. A., J. Nkengasong, T. Sibailly, C. Maurice, C. Adje, B. Monga, T. Roels, A. Greenberg, and S. Wiktor. 2002. Changes in plasma HIV-1 RNA viral load and CD4 counts, and lack of zidovudine resistance among pregnant women receiving short-course zidovudine. AIDS 16:625-630.
6. Emery, S., S. Bodrug, B. A. Richardson, C. Giachetti, M. A. Bott, D. D. Panteleeff, L. L. Jagodzinski, N. L. Michael, R. Nduati, J. Bwayo, J. K. Kreiss, and J. Overbaugh. 2000. Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya. J. Clin. Microbiol. 38:2688-2695.
7. Goedert, J. J., A. M. Duliege, C. I. Amos, S. Felton, and R. J. Biggar. 1991. High risk of HIV-1 infection for first-born twins. The international registry of HIV-exposed twins. Lancet 338:1471-1475.
8. Guay, L. A., P. Musoke, T. Fleming, D. Bagenda, M. Allen, C. Nakabiito, J. Sherman, P. Bakaki, C. Ducar, M. Deseyve, L. Emel, M. Mirochnik, M. G. Fowler, L. Mofenson, P. Miotti, K. Dransfield, D. Bray, F. Mmiro, and J. B. Jackson. 1999. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 354:795-802.
9. International Perinatal HIV Group. 1999. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1 - a meta-analysis of 15 prospective cohort studies. N. Engl. J. Med. 340:977-987.
10. John, G. C., R. W. Nduati, D. A. Mbori-Ngacha, B. A. Richardson, D. Panteleeff, A. Mwatha, J. Overbaugh, J. Bwayo, J. O. Ndinya-Achola, and J. K. Kreiss. 2001. Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections. J. Infect. Dis. 183:206-212.
11. Loveday, C., S. Kaye, M. Tenant-Flowers, M. Semple, U. Ayliffe, I. V. Weller, and R. S. Tedder. 1995. HIV-1 RNA serum-load and resistant viral genotypes during early zidovudine therapy. Lancet 345:820-824.
12. Minkoff, H., D. N. Burn, S. Landesman, J. Youchah, J. J. Goedert, R. P. Nugent, L. R. Muenz, and A. D. Willoughby. 1995. The relationship of the duration of ruptured membranes to vertical transmission of human immunodeficiency virus. Am. J. Obstet. Gynecol. 173:585-589.
13. Nielson, J., G. C. John, J. Carr, P. Lewis, J. Kreiss, S. Jackson, R. Nduati, D. A. Mbori-Ngacha, D. Panteleeff, S. Bodrug, C. Giachetti, M. Bott, B. Richardson, J. Bwayo, J. Ndinya-Achola, and J. Overbaugh. 1999. Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya. J. Virol. 73:4393-4403.
14. Nowak, M., S. Bonhoeffer, C. Loveday, P. Balfe, M. Semple, S. Kaye, M. Tenant-Flowers, and R. Tedder. 1995. HIV results in the frame. Nature 375:193.
15. Panteleeff, D. D., S. Emery, B. Richardson, C. Rousseau, S. Benki, S. Bodrug, J. Kreiss, and J. Overbaugh. 2002. Validation of the performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay for genital swabs and breast milk samples. J. Clin. Microbiol. 40:3929-3937.
16. Perelson, A. S., P. Essunger, Y. Cao, M. Vesanen, A. Hurley, K. Saksela, M. Markowitz, and D. Ho. 1997. Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 387:188-191.
17. Perelson, A. S., A. Neuman, M.'Markowitz, J. Leonard, and D. Ho. 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time, Science 271:1582-1586.
18. Shaffer, N., R. Chuachoowong, P. A. Mock, C. Bhadrakom, W. Siriwasin, N. L. Young, T. Chotpitayasunondh, S. Chearskul, A. Roongpisuthipog, and P. Chinayon. 1999. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Lancet 353:773-780.
19. UNAIDS. 2002. Report on the global HIV/AIDS epidemic. UNAIDS, Geneva, Switzerland.
20. Wang, C. C., S. McClelland, M. Reilly, J. Overbaugh, S. Emery, K. Mandaliya, B. Chohan, J. Ndinya-Achola, J. Bwayo, and J. Kreiss. 2001. The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1. J. Infect. Dis. 183:1017-1022.
21. Wei, X., S. Ghosh, M. Taylor, V. Johnson, E. Emini, P. Deutsch, J. Lifson, S. Bonhoeffer, M. Nowak, B. Hahn, M. Saag, and G. Shaw. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117-122.
22. Wiktor, S. Z., E. Ekpini, J. M. Karon, J. Nkengasong, C. Maurice, S. T. Severin, T. H. Roels, M. K. Kouassi, E. M. Lackritz, and I. M. Coulibaly. 1999. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d'lvoire: a randomised trial. Lancet 353:781-785.